Study of 2 years follow-up of referral patients with abnormal Pap smear

Fariba Behnamfar, Azam Zafarbakhsh, Taj-Alsadat Allameh

Abstract


Background: Abnormal Pap smear consists of premalignant or malignant cervical lesions. Many of premalignant cervical lesions will never progress to invasive malignancy, or even may regress over the time. Thus, there is always a risk of overtreatment of patients with an abnormal Pap smear. A long-term follow-up of these patients can reveal final events associated with each  subtype of abnormal Pap smear, and, therefore, help us to  prevent unnecessary interventions. The aim of our study was to present 2 years follow-up of referral patients with abnormal Pap smear. Materials and Methods: A total of 334 consecutive women aged more than 16 who were referred with an abnormal Pap smear were entered into the study. Patients were followed with biannual Pap smear and annual colposcopy and biopsy for  2 years. Results: At baseline, the majority of patients with  abnormal Pap smear were normal on colposcopy and biopsy (68% and 86%, respectively). Six months after first abnormal  Pap smear majority of patients in each group showed a significant regress to normal or less invasive lesion (P < 0.001). Twelve patients (4%) had no change in Pap smear, whereas 313 (94%) had at least one stage improvement. Only nine (3%) patients had deteriorated Pap smear after 6 months. All 308 patients who underwent colposcopy and biopsy had normal Pap  smear 24 months after the first abnormal Pap smear. Conclusion: Pap smear is associated with a high rate of false-positive results. In addition, the majority of low-grade cervical lesions can spontaneously regress. A long-term follow-up of a  patient with abnormal Pap smear can help us to avoid needless interventions.


Key words: Atypical squamous cell, cervical cancer, colposcopy, Pap smear


Full Text:

PDF